CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference39 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;J Ferlay;Int J Cancer,2010
2. Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, et al.. (2007) A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene 26: 4656–4667. Epub 2007 Feb 4612.
3. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis;H Brenner;Lancet,2002
4. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer;A Goldhirsch;J Clin Oncol,2001
5. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000;J Natl Cancer Inst,2001
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02
2. Identifying Key Regulatory Genes in Drug Resistance Acquisition: Modeling Pseudotime Trajectories of Breast Cancer Single-Cell Transcriptome;Cancers;2024-05-15
3. Identifying key regulatory genes in drug resistance acquisition: Modeling pseudotime trajectories of single-cell transcriptome;2024-04-28
4. CCNA2 and KIF23 are molecular targets for the prognosis of adenoid cystic carcinoma;Aging;2024-04-02
5. Characterization of runs of homozygosity islands in American mink using whole‐genome sequencing data;Journal of Animal Breeding and Genetics;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3